Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03531736
Title T Cell Depleted Allogeneic Hematopoietic Stem Cell Transplantation Conditioned With a Reduced Intensity Regimen in Patients With Hematologic Malignancies and Aplastic Anemia
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements Yes
Sponsors Memorial Sloan Kettering Cancer Center
Indications

acute myeloid leukemia

chronic lymphocytic leukemia

non-Hodgkin lymphoma

chronic myelomonocytic leukemia

myelodysplastic/myeloproliferative neoplasm

myelodysplastic syndrome

chronic myeloid leukemia

myeloproliferative neoplasm

multiple myeloma

Therapies

Rituximab

Cyclophosphamide + Fludarabine

Age Groups: senior | adult
Covered Countries USA

Additional content available in CKB BOOST